Your account is not claimed yet. You can sign up with ORCID to claim your account.

Karen Keeshan

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 10

Top Venues

Nature communications

The Journal of biological chemistry

Science signaling

Cancers

University of Glasgow

University College Cork National University of Ireland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Glasgow

United Kingdom

Reader (Associate Professor) :: Paul O'Gorman Leukaemia Research Centre

Education History

University College Cork National University of Ireland

Ireland

PHD :: Biochemistry

Publications

Chiara Pirillo, Flora Birch, Floriane S Tissot, Sara Gonzalez Anton, Myriam Luydmila Rachelle Haltalli, Valentina Tini, Isabella Kong, Cécile Piot, Ben Partridge, Constandina Pospori, Karen Keeshan, Salvatore Santamaria, Edwin Hawkins, Brunangelo Falini, Andrea Marra, Delfim Duarte, Chiu Fan Lee, Edward W Roberts, Cristina Lo Celso
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness. Blood advances 6 (10) (2022)
Anne-Louise Latif, Ashley Newcombe, Sha Li, Kathryn Gilroy, Neil Alistair Robertson, Xue Lei, Helen J S Stewart, John Cole, Maria Terradas Terradas, Loveena Rishi, Lynn McGarry, Claire McKeeve, Claire Reid, William Clark, Joana Campos, Kristina Kirschner, Andrew Davis, Jonathan Lopez, Jun-Ichi Sakamaki, Jennifer P Morton, Kevin M Ryan, Stephen W G Tait, Sheela A Abraham, Tessa Holyoake, Brian Higgins, Xu Huang, Karen Blyth, Mhairi Copland, Timothy J T Chevassut, Karen Keeshan, Peter D Adams
BRD4-mediated repression of p53 is a target for combination therapy in AML. Nature communications 12 (1) (2021)
Hamish D McMillan, Karen Keeshan, Anita K Dunbier, Peter D Mace
Structure vs. Function of TRIB1-Myeloid Neoplasms and Beyond. Cancers 13 (12) (2021)
Myint Myat Khine Aung, Megan L Mills, Joana Bittencourt-Silvestre, Karen Keeshan
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia. Molecular oncology 15 (9) (2021)
Izaskun Mitxitorena, Domenico Somma, Jennifer P Mitchell, Matti Lepistö, Christian Tyrchan, Emma L Smith, Patrick A Kiely, Helen Walden, Karen Keeshan, Ruaidhrí J Carmody
The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits. The Journal of biological chemistry 295 (33) (2020)
Laura Richmond, Karen Keeshan
Pseudokinases: a tribble-edged sword. The FEBS journal 287 (19) (2019)
Shahzya Chaudhury, Caitríona O'Connor, Ana Cañete, Joana Bittencourt-Silvestre, Evgenia Sarrou, Áine Prendergast, Jarny Choi, Pamela Johnston, Christine A Wells, Brenda Gibson, Karen Keeshan
Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias. Nature communications 9 (1) (2018)
Daniel M Foulkes, Dominic P Byrne, Wayland Yeung, Safal Shrestha, Fiona P Bailey, Samantha Ferries, Claire E Eyers, Karen Keeshan, Carrow I Wells, David Harold Drewry, William J Zuercher, Natarajan Kannan, Patrick A Eyers
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells. Science signaling 11 (549) (2018)
Mara Salomé, Aoife Magee, Krisha Yalla, Shahzya Chaudhury, Evgenia Sarrou, Ruaidhrí J Carmody, Karen Keeshan
A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling. Cell death & disease 9 (5) (2018)
Kai Ling Liang, Caitriona O'Connor, J Pedro Veiga, Tommie V McCarthy, Karen Keeshan
TRIB2 regulates normal and stress-induced thymocyte proliferation. Cell discovery 2 (2016)

Karen Keeshan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Karen Keeshan